@article {Nikitopoulou2021.07.30.21261361, author = {Ioanna Nikitopoulou and Dionysios Fanidis and Konstantinos Ntatsoulis and Panagiotis Moulos and George Mpekoulis and Maria Evangelidou and Alice G. Vassiliou and Vasiliki Dimakopoulou and Edison Jahaj and Stamatios Tsipilis and Stylianos E. Orfanos and Ioanna Dimopoulou and Emmanouil Angelakis and Karolina Akinosoglou and Niki Vassilaki and Argyris Tzouvelekis and Anastasia Kotanidou and Vassilis Aidinis}, title = {Increased Autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells}, elocation-id = {2021.07.30.21261361}, year = {2021}, doi = {10.1101/2021.07.30.21261361}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Autotaxin (ATX; ENPP2) is a secreted lysophospholipase D catalysing the extracellular production of lysophosphatidic acid (LPA), a pleiotropic signalling phospholipid. Genetic and pharmacologic studies have previously established a pathologic role for ATX and LPA signalling in pulmonary injury, inflammation, and fibrosis. Here, increased ENPP2 mRNA levels were detected in immune cells from nasopharyngeal swab samples of COVID-19 patients, and increased ATX serum levels were found in severe COVID-19 patients. ATX serum levels correlated with the corresponding increased serum levels of IL-6 and endothelial damage biomarkers, suggesting an interplay of the ATX/LPA axis with hyperinflammation and the associated vascular dysfunction in COVID-19. Accordingly, dexamethasone (Dex) treatment of mechanically ventilated patients reduced ATX levels, as shown in two independent cohorts, indicating that the therapeutic benefits of Dex include the suppression of ATX. Moreover, large scale analysis of multiple single cell RNAseq datasets revealed the expression landscape of ENPP2 in COVID-19 and further suggested a role for ATX in the homeostasis of dendritic cells, that exhibit both numerical and functional deficits in COVID-19. Therefore, ATX has likely a multifunctional role in COVID-19 pathogenesis, worth of suggesting that its pharmacological targeting might represent an additional therapeutic option.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been co-financed by the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call Research/Create/Innovate (project code: T1EDK/0049; recipient VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Evangelismos Hospital Research Ethics Committee ($\#$ 170/24-4-2020). The study was approved by the University Hospital of Patras Research Ethics Committee ($\#$ 216/08-05-2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are reported within the manuscript.}, URL = {https://www.medrxiv.org/content/early/2021/07/31/2021.07.30.21261361}, eprint = {https://www.medrxiv.org/content/early/2021/07/31/2021.07.30.21261361.full.pdf}, journal = {medRxiv} }